# Comparison of Two Qualia NAD⁺ Formulations on Intracellular NAD⁺ Levels

> **NCT07132801** · NA · NOT_YET_RECRUITING · sponsor: **Qualia Life Sciences** · enrollment: 180 (estimated)

## Conditions studied

- NAD
- NAD+ Levels in the Blood

## Interventions

- **DIETARY_SUPPLEMENT:** Qualia NAD⁺ version 1
- **DIETARY_SUPPLEMENT:** Qualia NAD⁺ version 2
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT07132801
- **Lead sponsor:** Qualia Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-13
- **Primary completion:** 2025-11-30
- **Final completion:** 2025-12-15
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2025-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07132801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07132801, "Comparison of Two Qualia NAD⁺ Formulations on Intracellular NAD⁺ Levels". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07132801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*